Prostate News Archive
24-May-2008
GTx shares fall on prostate cancer drug trial (AP via Yahoo! Finance)
Shares of biopharmaceutical company GTx Inc. fell Friday after the company said a late-stage trial of its prostate cancer drug candidate needs to continue, precluding an early filing with the Food & Drug Administration. Drug blocks prostate cancer in mice (UPI)
COLUMBUS, Ohio, May 23 (UPI) -- An experimental drug has blocked the progression of prostate cancer in mice with an aggressive form of the disease, Ohio State University researchers said. Data Re-analysis Shows Drug Finasteride May Reduce Risk For Most Prostate Cancers (Science Daily)
A re-analysis of data from the landmark Prostate Cancer Prevention Trial finds that finasteride may reduce the risk for prostate cancer without boosting the odds of aggressive tumors. Adjusting for prostate volume, findings from landmark PCPT trial refute notion that drug boosts aggressive disease. Experimental Agent Blocks Prostate Cancer In Animal Study (Science Daily)
An experimental drug has blocked the progression of prostate cancer in an animal model with an aggressive form of the disease, new research shows. The agent, OSU-HDAC42, belongs to a new class of drugs called histone deacetylase (HDAC) inhibitors, compounds designed to reactivate genes that normally protect against cancer but are turned off by the cancer process. The study showed that the agent ... Texas Rangers broadcaster Tom Grieve to have prostate surgery (Canadian Press via Yahoo! News)
ARLINGTON, Texas - Texas Rangers television analyst Tom Grieve, who was also a player and general manager in the organization, will have prostate surgery next month.
Back to Prostate News Archive
